Am. J. Respir. Cell Mol. Biol.,
Volume 19, Number 2, August, 1998 269-277
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
K. Hybiske, Z. Fu, C. Schwarzer, J. Tseng, J. Do, N. Huang, and T. E. Machen Effects of cystic fibrosis transmembrane conductance regulator and {Delta}F508CFTR on inflammatory response, ER stress, and Ca2+ of airway epithelia Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1250 - L1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Poschet, G. S. Timmins, J. L. Taylor-Cousar, W. Ornatowski, J. Fazio, E. Perkett, K. R. Wilson, H. D. Yu, H. R. de Jonge, and V. Deretic Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L712 - L719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez, A. C. Issler, C. U. Cotton, T. J. Kelley, A. S. Verkman, and P. B. Davis CFTR inhibition mimics the cystic fibrosis inflammatory profile Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L383 - L395. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Emam, A. R. Yu, H.-J. Park, R. Mahfoud, J. Kus, L. L. Burrows, and C. A. Lingwood Laboratory and clinical Pseudomonas aeruginosa strains do not bind glycosphingolipids in vitro or during type IV pili-mediated initial host cell attachment. Microbiology, September 1, 2006; 152(Pt 9): 2789 - 2799. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Machen Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol, August 1, 2006; 291(2): C218 - C230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Swiatecka-Urban, S. Moreau-Marquis, D. P. MacEachran, J. P. Connolly, C. R. Stanton, J. R. Su, R. Barnaby, G. A. O'Toole, and B. A. Stanton Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells Am J Physiol Cell Physiol, March 1, 2006; 290(3): C862 - C872. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Starner and P. B. McCray Jr. Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity To Eradicate Bacteria Ann Intern Med, December 6, 2005; 143(11): 816 - 822. [Full Text] [PDF] |
||||
![]() |
A. Muir, G. Soong, S. Sokol, B. Reddy, M. I. Gomez, A. van Heeckeren, and A. Prince Toll-Like Receptors in Normal and Cystic Fibrosis Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., June 1, 2004; 30(6): 777 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Kus, E. Tullis, D. G. Cvitkovitch, and L. L. Burrows Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients Microbiology, May 1, 2004; 150(5): 1315 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. van Heeckeren, A. Scaria, M. D. Schluchter, T. W. Ferkol, S. Wadsworth, and P. B. Davis Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L717 - L726. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lanotte, S. Watt, L. Mereghetti, N. Dartiguelongue, A. Rastegar-Lari, A. Goudeau, and R. Quentin Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins J. Med. Microbiol., January 1, 2004; 53(1): 73 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Kreiselmeier, N. C. Kraynack, D. A. Corey, and T. J. Kelley Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells Am J Physiol Lung Cell Mol Physiol, December 1, 2003; 285(6): L1286 - L1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bertrand and R. A. Frizzell The role of regulated CFTR trafficking in epithelial secretion Am J Physiol Cell Physiol, July 1, 2003; 285(1): C1 - C18. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, X. D. Johnson, S. Iazvovskaia, A. Tan, A. Lin, and M. B. Hershenson Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, February 1, 2003; 284(2): L307 - L315. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saba, G. Soong, S. Greenberg, and A. Prince Bacterial Stimulation of Epithelial G-CSF and GM-CSF Expression Promotes PMN Survival in CF Airways Am. J. Respir. Cell Mol. Biol., November 1, 2002; 27(5): 561 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Aldallal, E. E. McNaughton, L. J. Manzel, A. M. Richards, J. Zabner, T. W. Ferkol, and D. C. Look Inflammatory Response in Airway Epithelial Cells Isolated from Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1248 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Lyczak, C. L. Cannon, and G. B. Pier Lung Infections Associated with Cystic Fibrosis Clin. Microbiol. Rev., April 1, 2002; 15(2): 194 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kulka, M. Gilchrist, M. Duszyk, and A. D. Befus Expression and functional characterization of CFTR in mast cells J. Leukoc. Biol., January 1, 2002; 71(1): 54 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kelley, H. L. Elmer, and D. A. Corey Reduced Smad3 Protein Expression and Altered Transforming Growth Factor-beta 1-Mediated Signaling in Cystic Fibrosis Epithelial Cells Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Poschet, J. C. Boucher, L. Tatterson, J. Skidmore, R. W. Van Dyke, and V. Deretic Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung PNAS, November 20, 2001; 98(24): 13972 - 13977. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hertle, R. Mrsny, and D. J. Fitzgerald Dual-Function Vaccine for Pseudomonas aeruginosa: Characterization of Chimeric Exotoxin A-Pilin Protein Infect. Immun., November 1, 2001; 69(11): 6962 - 6969. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Weber, G. Soong, R. Bryan, S. Saba, and A. Prince Activation of NF-{kappa}B in airway epithelial cells is dependent on CFTR trafficking and Cl{-} channel function Am J Physiol Lung Cell Mol Physiol, July 1, 2001; 281(1): L71 - L78. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Schroeder, N. Reiniger, G. Meluleni, M. Grout, F. T. Coleman, and G. B. Pier Transgenic Cystic Fibrosis Mice Exhibit Reduced Early Clearance of Pseudomonas aeruginosa from the Respiratory Tract J. Immunol., June 15, 2001; 166(12): 7410 - 7418. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kube, L. Adams, A. Perez, and P. B. Davis Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L482 - L492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kube, U. Sontich, D. Fletcher, and P. B. Davis Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines Am J Physiol Lung Cell Mol Physiol, March 1, 2001; 280(3): L493 - L502. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Schroeder, T. Zaidi, and G. B. Pier Lack of Adherence of Clinical Isolates of Pseudomonas aeruginosa to Asialo-GM1 on Epithelial Cells Infect. Immun., February 1, 2001; 69(2): 719 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajan, G. Cacalano, R. Bryan, A. J. Ratner, C. U. Sontich, A. van Heerckeren, P. Davis, and A. Prince Pseudomonas aeruginosa Induction of Apoptosis in Respiratory Epithelial Cells . Analysis of the Effects of Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction and Bacterial Virulence Factors Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 304 - 312. [Abstract] [Full Text] |
||||
![]() |
G. B. Pier Role of the cystic fibrosis transmembrane conductance regulator in innate immunity to Pseudomonas aeruginosa infections PNAS, August 1, 2000; 97(16): 8822 - 8828. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Steagall, H. L. Elmer, K. G. Brady, and T. J. Kelley Cystic Fibrosis Transmembrane Conductance Regulator-Dependent Regulation of Epithelial Inducible Nitric Oxide Synthase Expression Am. J. Respir. Cell Mol. Biol., January 1, 2000; 22(1): 45 - 50. [Abstract] [Full Text] |
||||
![]() |
A. Saleh, C. Figarella, W. Kammouni, S. Marchand-Pinatel, A. Lazdunski, A. Tubul, P. Brun, and M. D. Merten Pseudomonas aeruginosa Quorum-Sensing Signal Molecule N-(3-Oxododecanoyl)-L-Homoserine Lactone Inhibits Expression of P2Y Receptors in Cystic Fibrosis Tracheal Gland Cells Infect. Immun., October 1, 1999; 67(10): 5076 - 5082. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Ratner, R. Bryan, A. Weber, S. Nguyen, D. Barnes, A. Pitt, S. Gelber, A. Cheung, and A. Prince Cystic Fibrosis Pathogens Activate Ca2+-dependent Mitogen-activated Protein Kinase Signaling Pathways in Airway Epithelial Cells J. Biol. Chem., May 25, 2001; 276(22): 19267 - 19275. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |